The story of Viagra, and its developer copyright, presents a complex case study for investors. At first a blockbuster drug, yielding billions in revenue , its patent expiration created a deluge of lower-priced https://thebookmarkfree.com/story21509888/sildenafil-and-pharma-a-uncertain-opportunity